Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases

•Rituximab has been used in autoimmune diseases other than rheumatoid arthritis.•Hypogammaglobulinemia is a well-known side effect of rituximab treatment.•Hypogammaglobulinemia has been associated with an increased risk of infection.•Prescriber may decide to initiate or continue rituximab despite hy...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International immunopharmacology 2023-07, Vol.120, p.110342-110342, Article 110342
Hauptverfasser:	Boumaza, Xavier, Lafaurie, Margaux, Treiner, Emmanuel, Walter, Ondine, Pugnet, Gregory, Martin-Blondel, Guillaume, Biotti, Damien, Ciron, Jonathan, Constantin, Arnaud, Tauber, Marie, Puisset, Florent, Moulis, Guillaume, Alric, Laurent, Renaudineau, Yves, Chauveau, Dominique, Sailler, Laurent
Format:	Artikel
Sprache:	eng
Schlagworte:	Agammaglobulinemia - chemically induced Agammaglobulinemia - drug therapy Agammaglobulinemia - epidemiology Arthritis, Rheumatoid - drug therapy Autoimmune Diseases - chemically induced Autoimmune Diseases - drug therapy Humans Hypogammaglobulinemia Infections - chemically induced Infectious risk Life Sciences Retrospective Studies Rituximab Rituximab - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!